Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture.


Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
20 May 2019
Historique:
received: 03 10 2018
accepted: 07 05 2019
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 30 8 2019
Statut: epublish

Résumé

Repeated culture reduces within-sample Mycobacterium tuberculosis genetic diversity due to selection of clones suited to growth in culture and/or random loss of lineages, but it is not known to what extent omitting the culture step altogether alters genetic diversity. We compared M. tuberculosis whole genome sequences generated from 33 paired clinical samples using two methods. In one method DNA was extracted directly from sputum then enriched with custom-designed SureSelect (Agilent) oligonucleotide baits and in the other it was extracted from mycobacterial growth indicator tube (MGIT) culture. DNA directly sequenced from sputum showed significantly more within-sample diversity than that from MGIT culture (median 5.0 vs 4.5 heterozygous alleles per sample, p = 0.04). Resistance associated variants present as HAs occurred in four patients, and in two cases may provide a genotypic explanation for phenotypic resistance. Culture-free M. tuberculosis whole genome sequencing detects more within-sample diversity than a leading culture-based method and may allow detection of mycobacteria that are not actively replicating.

Sections du résumé

BACKGROUND BACKGROUND
Repeated culture reduces within-sample Mycobacterium tuberculosis genetic diversity due to selection of clones suited to growth in culture and/or random loss of lineages, but it is not known to what extent omitting the culture step altogether alters genetic diversity. We compared M. tuberculosis whole genome sequences generated from 33 paired clinical samples using two methods. In one method DNA was extracted directly from sputum then enriched with custom-designed SureSelect (Agilent) oligonucleotide baits and in the other it was extracted from mycobacterial growth indicator tube (MGIT) culture.
RESULTS RESULTS
DNA directly sequenced from sputum showed significantly more within-sample diversity than that from MGIT culture (median 5.0 vs 4.5 heterozygous alleles per sample, p = 0.04). Resistance associated variants present as HAs occurred in four patients, and in two cases may provide a genotypic explanation for phenotypic resistance.
CONCLUSIONS CONCLUSIONS
Culture-free M. tuberculosis whole genome sequencing detects more within-sample diversity than a leading culture-based method and may allow detection of mycobacteria that are not actively replicating.

Identifiants

pubmed: 31109296
doi: 10.1186/s12864-019-5782-2
pii: 10.1186/s12864-019-5782-2
pmc: PMC6528373
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389

Subventions

Organisme : Wellcome Trust
ID : 203583/Z/16/Z
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : BRC/176/III/JB/101350
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P007597/1
Pays : United Kingdom
Organisme : Seventh Framework Programme
ID : 304875

Commentaires et corrections

Type : ErratumIn

Références

Emerg Infect Dis. 2006 May;12(5):752-9
pubmed: 16704831
Curr Opin Microbiol. 2007 Oct;10(5):504-9
pubmed: 17923431
Curr Protoc Microbiol. 2007 Aug;Chapter 10:Unit 10A.2
pubmed: 18770603
Am J Respir Crit Care Med. 2010 Jan 15;181(2):174-80
pubmed: 19875686
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Tuberculosis (Edinb). 2010 May;90(3):201-7
pubmed: 20435520
PLoS One. 2011;6(11):e27805
pubmed: 22125625
Tuberculosis (Edinb). 2012 May;92(3):194-201
pubmed: 22218163
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
PLoS One. 2012;7(6):e39754
pubmed: 22761889
J Infect Dis. 2012 Dec 1;206(11):1724-33
pubmed: 22984115
J Infect Dis. 2013 Nov 1;208(9):1464-73
pubmed: 23901086
PLoS One. 2013 Jul 30;8(7):e70178
pubmed: 23936157
PLoS One. 2013 Dec 06;8(12):e82551
pubmed: 24324807
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
Lancet. 2014 Sep 13;384(9947):1005-70
pubmed: 25059949
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
PeerJ. 2014 Sep 23;2:e585
pubmed: 25279265
Genome Biol. 2014 Nov 07;15(11):490
pubmed: 25418686
J Clin Microbiol. 2015 Jun;53(6):1908-14
pubmed: 25854485
Nat Commun. 2015 May 11;6:7119
pubmed: 25960343
J Clin Microbiol. 2015 Jul;53(7):2230-7
pubmed: 25972414
J Clin Microbiol. 2015 Aug;53(8):2716-9
pubmed: 26019203
Genome Med. 2015 May 27;7(1):51
pubmed: 26019726
Lancet Infect Dis. 2015 Oct;15(10):1193-1202
pubmed: 26116186
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
BMC Genomics. 2015 Oct 24;16:857
pubmed: 26496891
J Antimicrob Chemother. 2016 Apr;71(4):852-5
pubmed: 26507429
Clin Infect Dis. 2016 Feb 15;62(4):418-430
pubmed: 26508515
N Engl J Med. 2015 Nov 12;373(20):1986-8
pubmed: 26559594
Nat Commun. 2015 Dec 21;6:10063
pubmed: 26686880
MBio. 2016 Oct 25;7(5):
pubmed: 27795387
Nat Med. 2016 Dec;22(12):1470-1474
pubmed: 27798613
Lancet Infect Dis. 2017 Mar;17(3):275-284
pubmed: 27919643
J Clin Microbiol. 2017 May;55(5):1285-1298
pubmed: 28275074
Lancet Respir Med. 2017 Mar 15;:null
pubmed: 28344011
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
Genome Biol. 2017 Apr 19;18(1):71
pubmed: 28424085
PLoS One. 2017 May 18;12(5):e0176522
pubmed: 28545050
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1191-1201
pubmed: 28614668
Int J Infect Dis. 2017 Sep;62:44-46
pubmed: 28716462
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28893776
Clin Microbiol Infect. 2018 Jun;24(6):604-609
pubmed: 29108952
Mol Ecol. 2018 Jan;27(1):182-195
pubmed: 29165844
Nat Genet. 2018 Feb;50(2):307-316
pubmed: 29358649
J Clin Microbiol. 2018 Jul 26;56(8):
pubmed: 29848567
BMC Genomics. 2018 Aug 14;19(1):613
pubmed: 30107785
N Engl J Med. 2018 Oct 11;379(15):1403-1415
pubmed: 30280646
Mol Microbiol. 1995 Jan;15(2):235-45
pubmed: 7746145
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74
pubmed: 9275218

Auteurs

Camus Nimmo (C)

Division of Infection and Immunity, University College London, London, WC1E 6BT, UK. c.nimmo.04@cantab.net.
Africa Health Research Institute, Durban, South Africa. c.nimmo.04@cantab.net.

Liam P Shaw (LP)

UCL Genetics Institute, University College London, London, WC1E 6BT, UK.
Nuffield Department of Clinical Medicine, Oxford University, Oxford, OX3 7BN, UK.

Ronan Doyle (R)

Division of Infection and Immunity, University College London, London, WC1E 6BT, UK.
Clinical Research Department, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.

Rachel Williams (R)

Division of Infection and Immunity, University College London, London, WC1E 6BT, UK.

Kayleen Brien (K)

Africa Health Research Institute, Durban, South Africa.

Carrie Burgess (C)

Division of Infection and Immunity, University College London, London, WC1E 6BT, UK.

Judith Breuer (J)

Division of Infection and Immunity, University College London, London, WC1E 6BT, UK.

Francois Balloux (F)

UCL Genetics Institute, University College London, London, WC1E 6BT, UK.

Alexander S Pym (AS)

Africa Health Research Institute, Durban, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH